Scientific Published Reports
PREPRINTS
CONFERENCE POSTERS
Infectious Diseases, March 2024
ESWI 2024
Predicting the impact of next-generation vaccines on COVID-19, influenza and RSV disease outcomes using simulation methodology
Infectious Diseases, September 2024
OPTIONS XII
Forecasting the Seasonal Burden of Respiratory Infectious Diseases
Biorisk, October 2024
IDWeek 2024
The potential impact of vaccination on clade I mpox cases in the Democratic Republic of Congo, and Risk of Importation to the United States from International Travel
Download the ESC exclusive presentation
We’ll need a few short details about you and your business.
Analysis & Insights
Watch our on demand webinar on: Weight of the world: are anti-obesity therapeutics transforming the global health landscape for good
More from Airfinity
Wegovy costs $1.3m to prevent one heart attack, stroke, or cardiovascular death
Anti-obesity drug rush: Industry 'testing' nearly 190 candidates (es)
Weight loss injections could prevent 300,000 heart failures in the US by 2030, forecasts Airfinity
Airfinity forecasts the severely obese population with metabolic syndrome in the US to grow 50% by 2030 from 26 million to 39.1 million people.
View All →
What our users say?
“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”
Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister
“Airfinity has been instrumental in our country's COVID response.”
Head of UK Government
Vaccine Task Force
In a dynamic environment, Airfinity enabled us to remain on track with daily developments to enable more accurate decision-making. Airfinity combines nimbleness of real time data and their group of scientists that can analyse, model and provide strategic analysis for critical decision making.”
Iskra Reic, Executive Vice-President
Astrazeneca
“Probably the most expansive, accurate and helpful of the multiple data sets on an international scale”
Sir John Bell ,
University of Oxford